HKSE - Delayed Quote HKD

Good Fellow Healthcare Holdings Limited (8143.HK)

0.078
+0.001
+(1.30%)
At close: 2:44:51 PM GMT+8
Loading Chart for 8143.HK
  • Previous Close 0.077
  • Open 0.076
  • Bid 0.076 x --
  • Ask 0.097 x --
  • Day's Range 0.076 - 0.078
  • 52 Week Range 0.054 - 0.275
  • Volume 90,000
  • Avg. Volume 94,845
  • Market Cap (intraday) 43.965M
  • Beta (5Y Monthly) 0.53
  • PE Ratio (TTM) --
  • EPS (TTM) -0.000
  • Earnings Date Feb 10, 2025 - Feb 11, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Good Fellow Healthcare Holdings Limited, an investment holding company, provides general hospital services in the People's Republic of China and internationally. Its general hospital services include medical and surgical wards, and medical checkup and examination. The company operates general hospitals. It also provides medical investment and hospital management services. The company was formerly known as Hua Xia Healthcare Holdings Limited and changed its name to Good Fellow Healthcare Holdings Limited in February 2019. Good Fellow Healthcare Holdings Limited was incorporated in 2001 and is headquartered in Central, Hong Kong. Good Fellow Healthcare Holdings Limited is a subsidiary of Solar Star Global Limited.

www.gf-healthcare.com

118

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 8143.HK

View More

Performance Overview: 8143.HK

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

8143.HK
2.50%
HANG SENG INDEX (^HSI)
14.00%

1-Year Return

8143.HK
36.07%
HANG SENG INDEX (^HSI)
23.36%

3-Year Return

8143.HK
64.55%
HANG SENG INDEX (^HSI)
14.33%

5-Year Return

8143.HK
73.10%
HANG SENG INDEX (^HSI)
5.62%

Compare To: 8143.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8143.HK

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    56.02M

  • Enterprise Value

    64.93M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.41

  • Price/Book (mrq)

    4.79

  • Enterprise Value/Revenue

    2.79

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -10.09%

  • Return on Assets (ttm)

    -15.61%

  • Return on Equity (ttm)

    -24.01%

  • Revenue (ttm)

    23.27M

  • Net Income Avi to Common (ttm)

    -2.35M

  • Diluted EPS (ttm)

    -0.000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.92M

  • Total Debt/Equity (mrq)

    124.97%

  • Levered Free Cash Flow (ttm)

    -26M

Research Analysis: 8143.HK

View More

Company Insights: 8143.HK

Research Reports: 8143.HK

View More

People Also Watch